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INTRODUCTION
INTRODUCTION
           The greek word for liver is hepar, so medicinal terms related to liver often
start with hapato or hepatic. liver is the one of the largest organ in the body and
the cheif site for intense metabolism and excretion. It has a surprising role in the
maintenance, performance and regulating homeostasis of the body. It is involved
with almost all biochemical pathway to growth, fight against disease, nutrient
supply, energy provision and reproduction. The major function of the liver are
carbohydrate , protein and fat metabolism, detoxification, secretion of bile and
storage of vitamin. Thus, to maintain a healthy liver is a crucial factor for overall
health  and well  being.  But  when it  is  continuously and  variedly exposed to
environment toxins, chemicals like ccl4,  drug habits, alcohol, infection and auto
immune  disorders,  prescribed  (antibiotics,  chemotherapeutic  agents  like
paracetamol) cum over the counter drugs can eventually lead to various liver
ailments like  hepatitis, cirrhosis, and alcoholic liver disease1. 
      Liver damage is always associated with cellular necrosis, increase in tissue
lipid  peroxidation  and  depletion  in  the  tissue  glutathione  (GSH)  levels.  In
addition,  serum  levels  of  many  biochemical  markers  like  serum  glutamate
oxaloacetate  transaminase  (SGOT/AST)  and  serum  glutamate  pyruvate
transaminase  (SGPT/ALT)  triglycerides,  cholesterol,  bilirubin  and  alkaline
phosphates are elevated.
The following are some of the liver diseases that are commonly observed,
a) Necrosis
b) Cirrhosis
c) Hepatitis            – may be of viral, toxic or deficiency type.
d) Hepatic failure   – acute or chronic 
e) Liver  disorder  due  to  impairment  of  metabolic  function.  Generally  the
disorder associated with fat (liposis) and bilirubin (jaundice) metabolism are
very commonly seen.
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1. Disorder associated with fat metabolism: fatty liver
2. Disorder associated with bilirubin metabolism: jaundice or which may be of
different types based upon mechanism of action  and etiology.
a) Haemolytic/pre-hepatic jaundice.
b) Obstructive ( post-hepatic/cholestatic jaundice).
c) Hepatogenous/hepatic jaundice/cholstasis. 
In these three condition there occurs unconjucated hyperbilirubinaemia.
d) Hereditary  jaundice  or  pure  cholstasis:  gilberts  syndrome,  dubin  jhonson
syndrome and crigler-naijar syndrome etc, rotors syndrome are some of the
hereditary jaundice types.
e) Chemical/drug induced hepatotoxicity: generally may be hepatitis, jaundice
and carcinogenesis.
             Thus liver diseases are one of the fatal diseases in the world today. They
pose a serious challenge to international public health. Modern medicines have
little to offer for alleviation of hepatic diseases and it is chiefly the plant based
preparation which are employed for the treatment of liver disorder. But there are
not much drugs available for the treatment of liver disorders2,3.
            Herbal drugs provide significant source of hepatoprotective drugs. Mono
and poly-herbal preparation have been used in various liver disorders. According
to an estimate, more than 700 mono and poly-herbal preparations in the form of
decoction,  tincture,  tablets  and  capsules  from  more  than  100  plants  are  in
clinical use as hepatoprotective4.
            Therefore , many folk remedies from plant origin are tested for its
potential antioxidant and hepatoprotective liver damage in experimental animal
model.  Several  authors  have  reported  favourable  results  with  herbal  drugs
(mostly in the form of extracts) either in animals or in human  studies.  Ginkgo
biloba L.,   Echinacea  purpurea L.,   hypericum perforatum L.  and cimcifuga
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racemosa L Nutt. Were successfully subjected to clinical trials after preclinical
evaluation. 
Treatment option for common liver diseases such as cirrhosis, fatty liver, and
chronic  hepatitis  are  problematic.  The  effectiveness  of  treatment  such  as
interferon, colchicines, pencillamine and corticosteroids are inconsistent at best
and theincidence of side –effects profound. Too often the treatment is worse than
the disease.  Physicians and patients are in need of effective therapeutic agent
with a low incidence of side effects. Plants potentially constitute such agroup.
Several  hundred  plants  have  been  examined  for  use  in  a  variety  of  liver
disorders,5,6. 
The latter category of plants include:
• Silybum marianum (Milk thistle)
• Picorrhiza kurroa (Kutkin)
• Curcuma longa (Turmeric)
• Camellia sinensis (Tea)
• Glycyrrhiza glabra (Liqourice)
• Allium sativum (Garlic)
• Phyllanthus niruri and Eclipta alba
             These plants are hepatoprotective medicinal herbs, which have shown genuine
utility in liver disordes. These plants are used widely in hepatoprotective preparations
and extensive studies have been done on them. There are number of phytoconstituents
from plants which have exhibited hepatoprotective activity. Recent progress in the study
of such plants has resulted in the isolation of about 170 different phytoconstituents from
plants belonging to about 55 families, which exhibit hepatoprotective activity. 
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HEPATOTOXICITY
Hepatotoxin  is  a  toxic  substance  which  damages  the  liver.  Toxic  liver  injury
produced  by  drugs  and  chemicals  may  virtually  mimic  any  form  of  naturally
occurring liver disease. Hepatoprotective effect was studied against chemicals and
drugs  induced  hepatotoxicity  in  rats  like  alcohol,  carbon  tetra  chloride,
galactosamine, paracetamol, isoniazide and rifampicin, antibiotics, peroxidised oil,
aflatoxin etc.
Severiety  of  hepatotoxicity  is  greatly  increased  if  the  drug  is  continued  after
symptoms  develop.  Among  the  various  inorganic  compounds  producing
hepatotoxicity are arsenic, phosphorus, copper and iron. The organic agents include
certain naturally occurring plant toxins such as pyrrozolidine, alkaloids, myotoxins
and bacterial toxins7.
Liver injury caused by hepatotoxins, such as carbon tetra chloride (CCL4), ethanol,
and acetaminophen is characterised by varying degree of hepatocyte degeneration
and  cell  death  via  either  apoptosis  or  necrosis.  The  generation  of  reactive
metabolites  from the metabolism of  hepatotoxins  and  the  occurrence  of  reactive
oxygen species (ROS) during the inflammatory reaction, account for the variety of
pathophysiolocal  pathways  leading  to  cell  death,  such  as  covalent  binding,
disordered cytosolic calcium homeostasis, GSH depletion,  onset  of mitochondrial
permeability transition (MPT) and associated lipid peroxidation. The metabolism of
hepatotoxins by cytochrome P-450 enzyme subtypes is a key step of intoxication;
therefore, enzyme inhibitors are shown to minimize the hepatotoxin-associated liver
damage.  Moreover,  substantial  evidence   exists  that  MPT is  involved  in  ROS-
associated hepatocellular injury and few findings offer a novel therapeautic approach
to attenuate cell damage by blocking the onset of MPT. Thus, oxidant stress and
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lipid peroxidation are crucial elements leading to hepatotoxin-associated liver injury.
In  addition  to  specific  treatment  for  given  hepatotoxin,  the  general  strategy  for
prevention and treatment of the damage includes reducing the production of reactive
metabolites  of  hepatotoxins,  using anti-oxidative  agents  and  selectively targeting
therapeutics to kupffer cells or hepatocytes for on –going processes, which play a
role in mediating a second phase of injury8,.   
CLASSIFICATION OF HEPATOTOXINE9
A. Intrinsic
It consist of agents that are predictable hepatotoxins. They are recognised by higeh
incidence of hepatic injury exposed individuals and in experimental animals. There
is  a  consistent  latent  period  between  exposure  to  a  particular  agent  and  the
development of hepatic injury and the injury appeared to be dose related. There are
two types of intrinsic hepatotoxins.
1. Direct  hepatotoxins
It may be also called because they (metabolic products) produce direct ijury to
hepatocytes  and  its  organelles,  especially  the  endoplasmic  reticulam.  Example
carbon tetra chloride the proto type, produces peroxidation of the membrane lipids
and other chemicals that lead to degeneration of the membranes.
2. Indirect  hepatotoxins
They are  anti-metabolites  and  related  compounds that  produce  hepatic  injury by
interference with the specific metabolic pathway or processes. The structural injury
produced by indirect  hepatotoxins,  appear to be secondary to a metabolic region.
While  in  that  produced  by  direct  hepatotoxins,  the  metabolic  dearrangement  is
secondary  to  the  structural  injury.  The  hepatic  damage  produce  by  indirect
hepatotoxins may be mainly cytotoxic injury (by interfering with metabolic pathway
or processes essential for parenchyma integrity) expressed as steatosis or necrosis, or
may be mainly cholstasis, interfering only or mainly with biliary secretion.
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B. Host idiosyncrasy
It consist of agents that are not predictably hepatotoxic, but produces hepatic injury
in only a  small  portion of  exposed  individual.  Who are  uniquely susceptible.  In
several  instance  auto  antibodies  directed  against  normal  cellular  constituents  are
detected.  The  injury  does  not  appear  to  be  related  and  is  not  reproducible  in
experimental animals and appear after a variable latent period.
              EVALUATION OF HEPATOPROTECTIVE ACTIVITY10
             A review of literature reveals that several chemical substances and drugs having
specific action on liver are used as hepatotoxins in experimental animals to stimulate
ideal  diseased  conditions.  The  hepatoprotective  activity  can  be  most  easily
evaluated  /  screened  with  the  aid  of  several  model  systems  of  liver  damage  in
experimental animals.
            In all test model system, condition for liver damage are implemented and an attempt
is made to counteract this toxicosis with the substance preparation under test. The
magnitude  of  the  protective  effect  can  be  measured  by  estimating  the  enzyme
activities  and  the  rate  of  survival  and  can  be  verified  with  histologically.  The
available methods are  in-vivo, ex-vivo and in-vitro methods. All these methods are
used to study the protective or curative effect of any compound under test. In order
to  test  for  hepatoprotective  activity  the  test  substance  and  the  hepatotoxin  are
administered simultaneously whereas in case of anti hepatoxicity or curative  activity
the test substance is generally administered after induction of hepatotoxicity.
 
A. In vitro methods
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           Hepatocytes are generally isolated by using in-situ, two steps recirculating
collagenase  perfution  technique.these  are  then  seeded  in  small  containers  and
exposed to  test  samples  and toxins.  After  a  specified time period,  the degree  of
toxicity or protection is assessed by viability tests and enzyme levels such as GOT
and  GPT.  By  employing  primary  culture  hepatocytes  using  ccl4,  galatosamine,
thioacetamide,  ethanol,  paracetamol  (PCML)  etc,  as  hepatotoxins  several
hepatoprotective  screening  models  have  been  devised.  These  have  a  number  of
advantages over in-vivo methods such as their ability to dispose numerous sample at
a time, low cost with a small size, little variation and reproducibility of results. The
major disadvantage is that sometimes it may not reflect the events which occur in
animals.
B. In vivo methods
This  method is used only to study the nature of the given compound but also to
study the mechanism of  the toxicant.  Hepatotoxicity is  produced in  experimental
animals  by  the  administration  of  known  dose  of  hepatotoxins  like  CCL4,
galactosamine, thioacetamide, ethanol and paracetamol etc., which produced marked
measurable effects,  the magnitude of  which can be measured by carrying out  of
various liver function tests viz. Morphological, metabolic or functional, biochemical
and histopathological  determinations.  Although it  is  a  very convenient  laboratory
method,  reproducibility  of  results  is  rather  poor.  The  compounds  having
hepatoprotective claims are also evaluated in  general  for  their  choleretic  or  anti-
cholestatic  activity  in  order  to  know  whether  the  liver  disorder  is  due  to  an
abnormality  of  bilurubin  metabolism  or  not.  Choleretics  are  those  agents  which
increase the out puts of bile by stimulating the liver where as anti-cholestatis are
those  which  correct  the  retension  and  accumulation  of  bile  duo  to  intrinsic  and
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extrinsic factors in the liver.  These activities are evaluated by studying bile flow
content in conscious and anaesthetized by animals for 5 hours 
C. Ex vivo methods
In  this models, after completion of preselected in-vivo test protocol hepatocytes are
isolated  and  the  percentage  of  viable  cells  and  biochemical  parameters  are
determined as liver function tests. These methods are somewhat better correlated to
clinical models than in-vitro or in-vivo methods.
EXPERIMENTAL MODEL FOR HEPATOPROTECTIVE SCREENING
      Several chemical reagents and drugs which induce liposis, necrosis, cirrhosis,
carcinogenesis and hepatobiliary dysfunction in experimental animals are classified
as hepatotoxins. The following are the some of the experimental models explained
by employing some of the important hepatotoxins.
1. Paracetamol induced hepatotoxicity11,12.
2. Carbon tetra chloride induced hepatotoxicity13,14,15,16
3. D-galactosamine induced hepatotoxicity17.
4. Chloroform induced hepatotoxicity18.
5. Ethanol induced hepatotoxicity19,20,21.
6. Thioacetamide induced hepatotoxicity22.
PARACETAMOL INDUCED HEPATOTOXICITY11,12
Paracetamol or acetaminophen ( N-acetyl-p-aminophenol, APAP ) induced hepatic
injury are commonly used models for screening of hepatoprotective drugs and it
causes acute centriobular necrosis in rats, mice, guinea pig, hamsters, rabbits, cats,
dogs and pigs and centrizonal heamorrhagic necrosis in human mostly characterised
by pyknosis and eosinophillic cytoplasm.
Paracetamol  is  one  of  the  most  widely  used  drug  for  analgesic  and  antipyretic
activity  worldwide.  It  one  of  the  common  pharmaceutical  associated  with  both
intentional accidental poisoning. It is a major cause of liver failure and causes death
when taken in excess and is assumed to be safe inn recommended doses. It produces
hepatic necrosis at higher doses. Paracetamol is rapidly absorbed from the stomach
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and small intestine and metabolised by conjugation in the liver to non-toxic agents.
Therapeutic doses of drug are metabolised to sulphate and glucronide conjugates.
The rest is metabolised to a reactive intermediate which is detoxified by conjugation
with glutathione. In acute overdose or when the maximum daily dose is exceeded
over a prolonged period, the normal conjugative pathway of metabolism becomes
saturated.  Excess paracetamol is then oxidatively metabolised in the liver via the
mixed  function  oxidase  P-450  system  to  a  toxic  metabolite  N-acetyl-P-benzo-
quinoneimine  (  NAPQI  ).  NAPQI  has  extremely,  short  half  life  and  is  rapidly
conjugated  with  glutathione,  a  sulfhydryl  donor.  Under  condition  of  excessive
NAPQI formation or  reduced  glutathione store,  NAPQI covalently binds  to vital
proteins and the lipid bilayer of heatocyte membranes. The result is hepatocellulor
death and cenrilobular liver necrosis. Small are eliminated by conjugation followed
by excretion but when the conjugation enzymes are saturated, the drug is diverted to
an  alternative  metabolic  pathway,  resulting in  the  formation of  a  hydroxylamine
derivative by cytochrome P-450 enzyme. The hydroxylamine derivative, a reactive
electrophillic  agent,  reacts  non  enzymatically  with  glutathione  reacts  with
macromolecules and disrupts their structure and function. Extensive liver damage by
paracetamol itself decreases its rate of metabolism and other substrates for hepatic
microsomal enzymes.  Induction of P-450 or depletion of hepatic glutathione is  a
prerequisite  for  paracetamol  induced  toxicity.  In  over  dose,  the  sulphate  and
glucuronide conjugation pathways are saturated and more drugs are converted to the
reactive  metabolites  accumulated  bind  covalently  to  liver  cell  proteins,  causing
irreversible damage. Liver damage can be prevented by providing glutathione like
substances, such a acetylcystine, so that the reactive metabolite can be removed by
conjugation and the liver cells are protected. An alternative view is that oxidative
stress has a role in hepatotoxicity. There are many characteristic features of oxidative
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stress in APAP hepatotoxicity,  including lipidperoxidation, mitochondrial  damage,
ATP depletion, and formation of nitrotyrosine adducts in proteins, presumably owing
to formation of superoxide-derived peroxynitrite. However, these processes may be
consequences of the damage mediated by protein adduction rather than the  direct
effect of hepatotoxicity.
              
            PARACETAMOL-INDUCED HEPATOTOXICITY
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PATHOPHYSIOLOGY OF HEPATOXICITY:
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ANALYSIS  OF  BIO  CHEMICAL  PARAMETER  TO  ASSESS  LIVER
FUNCTION
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In keeping with the multiplicity of the liver, a variety of tests are available to assess
them. The choice of the test is influenced by its simplicity, reliability, and sensitivity
as well as the particular function, one is interested in assessing.
1. Serum enzyme parameters
            Transaminases 
A transamination is a process in which an amino group is transferred from an amino
acid to alpha- keto acid. It is an important step in the metabolism of amino acids. The
enzyme  responsible  for  transamination  are  called  transaminases  or  samino-
transferases.  Two  diagnostically  useful  transaminases  are  glutamate  oxaloacetate
transaminase SGOT/SAT and glutamate pyruvate trasaminase SGPT/ALT. These two
enzymes are sensitive markers of hepato-cellular injury. 
A. Estimation of SGOT/AST22,23,24
Principle
SGOT (AST)  catalyses  the  transfer  of  amino  group  SGOT is  an  enzyme found
mainly in  heart  muscle,  liver  cells, skeletal  muscle  and  kidneys.  Injury to  these
tissues results in the release of the enzyme in blood.  Elevated levels are found in
myocardial  infarction,  cardiac  operations,  hepatitis,  cirrhosis,  acute  pancreatitis,
acute renal diseases and primary muscle diseases. Decreased levels may be found in
pregnancy,  Beri  Beri  and  Diabetic  ketoacidosis.  Its  normal  serum  level  is  5-40
units/I.
between L-Aspartate and a ketoglutarate to form oxaloacetate and glutamate. The
oxaloectate formed reacts with NADH in the presence of malate dehydrogenase to
form NAD. The rate of oxidation of NADH to NAD is measured as a decrease in
absorbance which is proportional to the SGOT (AST) activity in the sample.
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                                                       AST
L-Aspartate + α-ketoglutarate ------------------> oxaloacetate + L-Glutamate
                                                      MDH
Oxaloacetate + NADH +  H+ -----------------> L-Malate + NAD+
SGOT levels  are 10-200 fold elevated in patients with acute hepatic necrosis, viral
hepatitis and drug induced poisoning. SGOT levels are also elevated by 10 fold in
patient of post hepatic jaundice,  intra hepatic cholestasis and less than 10 fold in
alcoholic and hepatic steatosis. Very high levels are seen in extensive acute hepatic
necrosis such as in severe viral hepatitis and acute cholestasis. 
B. Estimation of SGPT/ALT25,26,27
SGPT or ALT is a cytosolic enzymes primarily present in the liver. Its normal serum
level is 7-56 units/I.
Principle
SGPT  (ALT)  catalyses  the  transfer  of  amino  group  from  L-alanine  to  alpha-
ketoglutarate  to  yield  pyruvate  and  L-glutamate.  Lactate  dehydrogenese  then
converts pyruvate and NADH into lactate and NAD. The conversion of NADH  to
NAD decreases the absorbtion at  340 nm. The rate  of  decrease in absorbance is
measured and is proportional to the SGPT activity.
                                                  
                                                    ALT
L-alanine + α-ketoglutarate --------------------> pyruvate + L-Glutamate
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                                                    LDH
Pyruvate + NADH + H+ -----------------------> L- Lactate + NAD+
ALT  activity  is  predominantly  associated  with  liver  tissues  followed  by
comparatively lower levels in heart, muscle and kidneys. Quantitation of ALT is a
useful  parameter in evaluating liver function.  Elevated levels of the enzymes are
found in liver and kidney diseases such as infectious or toxic hepatitis, infectious
mononucleosis and cirrhosis, moderate increase is also found in obstructive jaundice,
metastasis carcinoma, hepatic congestion and myocardial infarction. 
Phosphatases
Phosphatases  belongs  to  the  class  of  enzymes  called  hydrolases  and  they  are
characterized by their ability to hydrolyse a large variety of organic phosphates with
the formation of an alcohol and phosphate ions.               
Phosphatases  of  diagnostic  significance  are  alkaline  phosphatases  and  acid
phosphatises.  These  are  differentiated  by  their  reaction  in  alkaline  and  acidic
medium. The PH for measuring the alkaline phosphatase activity is 10 and for acid
phosphatase is 5.
Alkaline phosphatase28,29,30 (ALP)
ALP  is  a  membrane  bound  glycoprotein  enzyme,  produced  by  many  tissues,
especially bone, liver, intestine, placenta and is excreted into the bile. Elevation in
activity of the enzyme can thus be found in diseases of bone, liver and in pregnancy.
ALP levels in serum are abnormally high in biliary obstruction, slight to moderate
increase in seen in parenchymal liver diseases such as in hepatitis and cirrhosis and
in metastatic liver disease. Its normal serum level is 20-100 U/L.
Page 16
HEPATOTOXICITY
Principle  
The  substrate,  p-nitrophenyl  phosphate  (PNPP)  is  hydrolysed  by  ALP  to  p-
nitrophenol (PNP)(colourless) and phosphoric acid,  PNPP is colourless in acid or
alkaline medium while PNPis yellow in the alkaline medium and colourless in acid
mediumand the concentration is determined by measuring the absorbance at 405 nm.
                                                                 ALP
P-nitrophenyl  phosphate  +H2O----------------->  P-nitrophenol  +   H3PO4
  (colourless)                 (yellow)
Increased alkaline phosphatase activity may be related to hepatobiliary and bone
diseases. Very high alkaline phosphatases activity in serum is seen in patient with
bone cancer  and marked increased also occur  in  obstructive jaundice and biliary
cirrhosis.  Moderated  elevations  havebeen  noted  in  case  of  Hodgkin,s  disease,
congestive heart failure, infective hepatitis and abdominal problems. 
2. Bile pigments
Billirubin  or  hematoidin  is  the  yellow  breakdown  product  of  normal  heme
catabolism. Heme is found in haemoglobin, a principle component of red blood cells.
Bilirubin  excreted  in  bile  and  urine,  and  elevated  levels  may  indicate  certain
diseases.  It  is  responsible  for  the  yellow colour  of  brusis,  urine  and  the  yellow
discolouration in jaundice. Bilirubin in serum would only react with diazo reagent in
the  presence  of  alcohol,  after  the  proteins  had  been  removed  by  precipitation.
Normally  0.25mg/dl  of  conjugated  bilirubin  is  present  in  the  blood  of  an  adult.
Bilirubin  rises  in  disease  of  hepatocytes,  obstruction  to  biliary  excretion  into
duodenum in haemolysis, and defects of hepatic uptake and conjugation of bilirubin
pigment such as Gilbert,s disease. Estimation of bilirubin is one of the better liver
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function tests because the liver must take bilirubin away from the albumin to which
it is bound in the circulation, conjugate it and excrete it into the bile-a truly complex
series of reaction.
Estimation of serum total bilirubin31,32,33 (TB) 
The serum bilirubin level  is  one of  the best  tests  of  liver  function tests  of  liver
function. Bilirubin is the metabolic product of the breakdown of the haeme derived
from senescent redblood cells .each day about 7.5g of haemoglobin is catabolised
with  the  corresponding  production  of  250  mg  bilirubin.  Normally,  025mg/dl  of
conjugated bilirubin present in the blood of an adult. Bilirubin level rises in diseases
of hepatocytes, obstruction to billiary excretion into duodenum, in haemolysis and
defects of hepatic uptake and conjugation of bilirubin treatment such as  Gilbert,s
disease.
Principle
Bilirubin  reacts  with  diazotized  sulphanilic  acid  to  form  an  azo  compound,  the
colour of which is measured at 546 nmand is proportional to the concentration of
bilirubin. The stability of final colour of reaction of mixture is 10 minutes for total
bilirubin and 5 minutes for direct bilirubin.
3. Estimation of serum total protein34,35 (TP)
Principle
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The peptide bond of protein react with CU2+  ions in alkaline solution to form a blue
violet complex (Biuret reaction), each copper ion complexing with 5 or 6 peptide
bonds. Tarterate is added as stabilizer while iodine is used to prevent auto reduction
of  alkaline  copper  complex.  The  color  formed  is  proportional  to  the  protein
concentration and is measured at 546 nm.   
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Sowjanya  G et al,. 20131
Liver diseases are a major problem of worldwide proportions and liver damage
is very common since liver has the capacity to detoxicate toxic substances. In
this review some of the plants with their extract studied for protective effect in
liver diseases were summerised. The varios isolated compounds studied herein
are  Andrographolide,  neoandrographolide,  bacoside-A,  colchicine,  populnin,
naringenin,  echinacoside,  kolaviron,  ternatin,  indigtona,  rubiadin,  bacicalein,
baicalin,  wogonin,  punicalagin,  punicalin  for  their  hepatoprotective  activity.
There  are  several  chemicalshave  been  known  to  induce  heptotoxicity  by
producing  reactive  species  which  cause  depletion  in  tissue  thiol,  lipid
peroxidation, plasma membrane damage like carbon tetrachloride, paracetomol,
thioacetamide,  antituberculer  drugs,  D-galactosamine,  liposachharide  and
arsenic etc.
Schandalik R et al,. 19922
Liver diseases are among the most serious ailment and can be classified as acute
or chronic hepatitis (inflammatory liver disease), hepatosis (non inflammatory
diseases) and cirrhosis (degeneration disorders resulting in fibrosis of the liver).
Beside expensive and ineffectual modern therapeutic agents like steroids and
chemotherapy, south east Asian countries like India and China have an edge in
treating hepatic disorders by means of their native botanicals. No doubt,  the
botanicals  need  to  follow proper  standardization  and  quality  control  modus
operandi before their therapeutic usage in human ailments but the applicability
in  this  regard  has  shown  exceptional  success.  This  review  is  focused  on
important  botanicals  standardized  for  chemical  markers,  which  have  shown
promising results as hepatoptotective agents.
Sanjay Kumar Jain et al,. 20133,4,5,
Medicinal practitioners have prescribed Ayurveda and drug from herbal origin
as  a  system  of  medicine  in  India  over  centuries.  Popularity  of  herbal  is
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increasing globally. More efforts need to be directed towards methodological
scientific  evaluation  for  their  safety and  efficacy  by subjecting  to  vigorous
preclinical studies followed by clinical trials to unravel the mysteries hidden in
plants. Hepatic disease stand as one of the foremost health troubles worldwide
with liver cirrhosis and drug induced liver injury accounting 9th leading cause
of death in western and developing countries. In this review article attempt has
been made to compile reported hepatoprotective plants from India and aboard
and may be useful  to health professional’s scientists’ scholar working in the
field  of  pharmacology,  therapeutics  and pharmacognosy to  develop evidence
based alternative medicine to cure different kinds of liver disease in man and
animals.
Sowjanya et al,. 20138,9
In this review some of the plants with their extract studied for protective effect
in  liver  diseases  were  summerised.  The  varios  isolated  compounds  studied
herein  are  Andrographolide,  neoandrographolide,  bacoside-A,  colchicine,
populnin,  naringenin,  echinacoside,  kolaviron,  ternatin,  indigtona,  rubiadin,
bacicalein, baicalin, wogonin, punicalagin, punicalin for their hepatoprotective
activity. There are several chemicals have been known to induce heptotoxicity
by  producing  reactive  species  which  cause  depletion  in  tissue  thiol,  lipid
peroxidation, plasma membrane damage like carbontetrachloride, paracetomol,
thioacetamide,  antituberculer  drugs,  D-galactosamine,  liposachharide  and
arsenic etc.
Rachmilewitz et al,. 195010,11,12
Paracetamol toxicity is due to the formation of a toxic metabolite (N-acetyl-p-
benzoquinoneimine)  when  it  is  metabolized  by  cytochrome  P450s,  which
causes oxidative stress and glutathione depletion.
Rage N et al,. 195913,
The  hepatotoxic  effects  of  carbon  tetrachloride  are  largely due  to  its  active
metabolite, the trichloromethyl radical. These activated radicals bind covalently
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to  the  macromolecules  and  induce  lipid  peroxidative  degradation  of
biomembranes, leading to liver damage.
M. B. Shankar et al,. 200515
The hepatoprotective activity of a  new benzopyrone derivative (TP) isolated
from  the  alcoholic  extract  of  aerial  parts  of  Tephrosia  purpurea.
Hepatoprotective activity of TP and the alcoholic extract was evaluated using
carbon tetrachloride, paracetamol and rifampicin as toxicants. The potency of
TP (100  mg/kg)  and  the  alcoholic  extract  of  aerial  parts  (200  mg/kg),  was
compared  with  silymarin  (100  mg/kg).  The  SGOT,  SGPT,  total  and  direct
bilirubin  levels  of  blood  were  measured  spectrophotometrically  Alcoholic
extract of T. purpurea and TP have shown significant hepatoprotective activity
in rats against all the toxicants that were studied.
Saraf S et al,. 199216
It produces hepatotoxicity with extensive central necrosis, fatty metamorphosis,
hepatic cell degeneration and necrosis either by inhalation or by subcutaneous
administration (0.4-1.5ml/kg
Kiso Y et al 198317
D-galactosamine  (800mg/kg  i.p.)  induces  acute  hepatotoxocity  after  48  hrs  of
administration with diffused necrosis and steatosis in male wister rats.
Thripati et al,. 199120
Hepatoprotective  activity  of  Picroliv  against  alcohol-carbon  tetrachloride
induced damage in rats.
Gulati, R et al,. 199121
Hepatoprotective  activity  of  Boerhaavia  diffusa  Linn.  Against  country made
liquor induced toxicity in albino rats fed on controlled calorie diet for 7 days .
Goodell et al,. 194422
Thioacetamide (100mg/kg s.c.) induces acute hepatic damage after 48 hrs of
administration by causing sinusoidal  congestion and hydropic swelling with
increased mitosis.
Reitman S et al,. 195728
After  48  h  of  paracetamol  and  carbon  tetrachloride  and  24  h  of  ethanol
administration,  the blood was obtained from animals by puncturing the retro
orbital  plexus.  The blood samples  were allowed to  clot  for  45 min at  room
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temperature. The serum was separated by centrifugation at 2500 rpm at 30°C
for 15 min and utilized for the estimation of various biochemical parameters
including  SGOT and SGPT, ALP, serum bilirubin, serum protein, and serum
cholesterol. After the collection of blood samples, the animals were sacrifi ced
under  deep  ether  anesthesia  and  their  livers  were  excised  immediately  and
washed  with  ice  cold  saline,  and  a  10%  homogenate  was  prepared  in  a
phosphate buffer (pH 7.0). The homogenate was centrifuged at 3000 rpm for 15
min at 4°C and the supernatant was used for the estimation of glutathione and
lipid peroxidation. 
Balakrishnan L et al,. 201332
Significant hepatoprotective effects were obtained against liver damage induced
by all the  toxins, as evident from changed biochemical parameters like serum
transaminases  (SGOT and  SGPT),  alkaline  phosphate  (ALP),  total  bilirubin,
total protein, and total cholesterol. The results indicate that CCF and PDF could
be useful in preventing chemically induced acute liver injury.
Chakraborty et al,. 201149,50,51
The  effect of the warm aqueous extract of  Lawsonia inermis  leaf on Carbon
tetrachloride (CCl4) induced liver  damage in  healthy Wister  albino rats  was
studied.  The  results  showed  that  significant  hepatoprotective  effects  were
obtained  against  liver  damage  induced  by CCl4  as  evidenced  by decreased
levels of serum enzymes, glutamate pyruvate transaminase (SGPT), glutamate
oxaloacetate transaminase (SGOT), serum alkaline phosphatase (SAKP), serum
bilirubin (SB). The extracts also showed significant antilipid peroxidant effects
in vitro, besides exhibiting significant activity in quenching 1, 1‐diphenyl  ‐2‐
picryl hydrazyl (DPPH) radical indicating its potent antioxidant effects.
 Chaudhary et al,. 201052
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Lawsonia inermis L. is a much branched glabrous shrub or small tree, cultivated
for its leaves although stem bark, roots, flowers and seeds have also been used
in traditional medicine. The plant is reported to contain carbohydrates, proteins,
flavonoids, tannins and phenolic compounds, alkaloids, terpenoids, quinones,
coumarins,  xanthones  and  fatty  acids.  The  plant  has  been  reported  to  have
analgesic,  hypoglycemic,  hepatoprotective,  immunostimulant,  anti-
inflammatory,  antibacterial,  antimicrobial,  antifungal,  antiviral,  antiparasitic,
antitrypanosomal,  antidermatophytic,  antioxidant,  antifertility,  tuberculostatic
and anticancer properties. It is now considered as a valuable source of unique
natural products for development of medicines against various diseases and also
for the development of industrial products. This review gives a bird’s eye view
mainly on the pharmacognostic characteristics, traditional uses, phytochemistry
and pharmacological actions of the plant.
Chang H et al,. 198253
Aqueous extract of leaves of L. inermis was found to inhibit sickling and to 
increase the oxygen affinity of HbSS blood.
 Dasgupta T et al,. 200354
Modulator  effect  of  80  %  ethanol  extract  of  leaves  of  henna  on  drug
metabolising  phase  I  and  phase  II  enzymes,  antioxidant  enzymes,  lipid
peroxidation  in  the  liver  of  Swiss  Albino  mice.  The  hepatic  glutathione  S-
transferase and DTdiaphorase specific activities were elevated above basal level
by  L.  inermis  extract  treatment.  With  reference  to  antioxidant  enzyme  the
investigated doses were effective in increasing the hepatic glutathione reductase
(GR), superoxide dismutase (SOD) and catalase activities significantly at both
the dose levels. Reduced glutathione (GSH) measured as non-protein sulphydryl
was found to be significantly elevated in liver. Among the extrahepatic organs
examined  (forestomach,  kidney  and  lung)  glutathione  S-transferase  and
DTdiaphorase level were increased in a dose independent manner. 
 Aguwa CN et al,. 198755
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Methanol extract of roots of L. inermis was most effective in inducing abortion
in mice, rats and guinea pig. The effect apparently was dosage dependent. The
results  of  the  whole  animal  experiments  support  the  methanol  extract
effectiveness as an abortant due to its maternal and foetal toxic effects.
   Yogisha S et al,. 200256
The  ethanol  extract  of  L.  inermis  L.  leaves  and  lawsone  tested  for  trypsin
inhibitory activity showed an IC50 value of 64.87 and 48.6µg/ml, respectively.
 Khan M et al,. 199157
The ethanol soluble fraction of L. inermis fruits displayedhighly potent activity
against  Sembiki  forest  virus (SFV) in swiss mice and chick embryo models
exhibiting 100 to 65 % activities after 10 to 25 days of virus challenge.
 Endrini S et al,. 200758
Chloroform  extract  of  leaves  of  L.  inermis  displayed  the  cytotoxic  effects
against liver (HepG2) and Human breast (MCF-7) with IC50 values of 0.3 and
24.85µg/ml by microculture tetrazolium salt assay (MTT).
 Syamsudin et al,. 200859                                                                            Activity
of  Ethanol (70%) extract showed significant Hypoglycaemic and 
hypolipidaemic   activities   in alloxan   induced   diabetic   mice after oral 
administration.
Endrini et al., 200760                                                                               
Chloroform  extract   of leaves of Lawsonia inemris had  shown   the  highest 
activity (87.6%) followed by α-tocopherol (62.5%) by using FTC method and 
based on TBA method significant activity (55.7 %) compared to α-tocopherol 
(44.4%).
 Selvanayagi R et al,. 201261,62
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The hepatoprotective activity of aqueous extract of  lawsonia inermis against
paracetamol  induced hepatotoxicity in  rats.  The aqueous extract  of  lawsonia
inermis  administered  orally  to  the  animals  with  hepatotoxicity  induced  by
paracetamol. Silymarin was given as a reference standard. The plant aqueous
extract  was  effective  in  protecting  the  liver  against  the  injury  induced  by
paracetamol induced toxicity.  This was evident  from significant reduction in
serum enzymes ALT, AST, ALP, ACP, protein and bilirubin. 
Gupta A et al,. 198663
Isoplumbagin and lawsaritol, isolated from stem bark and root of L. inermis L.
showed anti- inflammatory activity against Carrageenan induced paw oedema in
rats. The compounds phenylbutazone, isoplumbagin and lawsaritol at the oral
dose of  100 mg/kg exhibited  and 40 percent inhibition in comparison with
controls. Isoplumbagin showed significant anti- inflammatory activity similar to
that of phenylbutazone.  Butanol and chloroform fractions showed more potent
anti-inflammatory,  analgesic  andantipyretic  effects  than  aqueous  fraction  of
crude ethanol extract of L. inermis in a dose dependent manner.  Leaves showed
significant anti-inflammatory effect with some active principles. 
Bhanwa et al, 2000 64                                                                                          
Studied the effect of aqueous leaf extract of  azadirachta indica in paracetamol-
induced  hepatotoxicity  in  rats. The  liver  damage  due  to  paracetamol
administration resulted in elevation in the activities of serum transaminases and
gamma glutamyl transpeptidase (GGT). The extract of A.indica was found to be
effective  in  reducing  paracetamol-induced  liver  necrosis  as  evidenced  by
histopathological studies.
Aniya et al., 200065   
 Aqueous extract of Artemisia campestris exhibited hepatoprotective and anti
oxidant activities (in vivo and in vitro). The extract showed scavenging action
of  1,1,diphenyl  picrylhydrazyl,  hydroxyl  and  superoxide  anion  radicals.
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Pretreatment  (intraperitoneal/oral)  with  the  extract  significantly  reduced  the
CCL4  evoked elevation of serum transaminases in mice. The authers suggested
thet  the  proactive  action of  A.campestris  extract  may be  due  to  scavenging
action of the plant for free radicals formed by CCL4 treatment.
 Ahmed et al., 200066
 Pre-treatment of rats with the 50% ethanol extract of the bark of lawsonia alba 
showed hepatoprotective activity against CCL4 induced oxidative stress. The 
prptective activity of the extract was shown by the reduction in the activities of 
serum transaminases and lactate dehydrogenase (LDH) in the rats against in the 
activities of the enzymes when challenged with CCL4 . moreover, the plant 
extract prevented CCL4 induced oxidative stress by maintaining the levels of 
reduced glutathione, its metabolising enzymes and simultaneously inhibiting the
production of free radicals.  
Desmarchelier et al., 199967
The  in  vitro  antioxidant  and  free  radical  scavenging  properties  of  the  park
extract of anadenanthera macrocarpa, astronium urundeuva, mimosa verrucosa
and sideroxylon obtusifolium were studied using different  bioassays.  All  the
extracts (aqueous and methanolic extract) were active.
Bhaka et al., 199968
Evaluated the antihepatotoxic of  n-heptane extract  of cassia fistula leaves  in
CCL4 :  liquid  paraffin   (1:1)  treated  rats.Biochemical  and  histopathological
investigation indicated that the extract of C.fistula (400 mg/kg body weight) has
hepatoprotective effect.
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Jafri et al., 199969
Biochemical  and  histopathological  studies  on  the  effect  of  the  leaves  of
C.occidentalis  (aqueous-ethanolic  extract)  on  paracetamol  and  ethanol
intoxication in rats revealed its hepatoprotective activity.
 Lalitha and selvam., 199970                                                                      
Turmeric  antioxitant  protein  isolated  from  the  aqueous  extract  of  turmeric
(Curcuma longa) has been found to exhibit  hepatoprotection in CCL4-treated
rats.  The studies shown the decrease in the activities of antioxidant enzymes in
liver  due to CCL4  intoxication was nearly normolized on treatment with the
protein. The authers suggest that the protection exhibited by the protein may be
due to the stabilization of the oxidative stress induced changes.
 Germane et al., 199971                                                                                     The
studied effect of Mitracarpus scaber (decoction of aerial parts) on CCL4-induced
acute liver damage (in vivo and in vitro) in rats. In vivo results showed that pre-
treatment with M.scaber reduced the elevated activities of serum GOT and GPT 
due to CCL4 treatment. In vitro results indicated that addition of M.scaber 
extracts to the culture medium reduced the CCL4-evoked elevation in the 
activities of serum GOT and GPT. In vitro study also revealed the free radical 
scavenging properties of M.scaber.
Manjunath BK et al,. 200872
Aqueous  and  ethanol  extract  of  leaf  of  Vitex  trifolia  was  investigated  for
hepatoprotective activity against carbon tetrachloride induced liver damage. To
assess  the  hepatoprotective  activity  of  the  extracts,  various  biochemical
parameters  viz.  total  bilirubin,  total  protein,  alanine  transaminase,  aspartate
transaminase and alkaline phosphatase activities were determined. Results  of
the  serum  biochemical  estimations  revealed  significant  reduction  in  total
bilirubin and serum marker enzymes and increase in total protein in the animals
treated with ethanol  and aqueous extracts.  However  significant  rise  in  these
serum enzymes and decrease in total protein level was noticed in CC14 treated
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group  indicating  the  hepatic  damage.  The  hepatoprotective  activity  also
supported by histological studies of liver tissue. Histology of the liver tissue
treated with ethanol and aqueous extracts showed normal hepatic architecture
with few fatty lobules. Hence the present study revealed that Vitex trifolia could
afford significant protection against CCl4 induced hepatocellular injury.
Patel JA et al,. 200973,74,75,76,
Piper longum Linn. (Piperaceae) (Fruits and roots powder) is given with boiled
milk  in  the  Indian  traditional  system of  medicine  for  the  treatment  of  liver
ailments  and  jaundice.  However,  the  biochemical  basis  and  mechanism  of
hepatoprotective  action  of  Piper  longum  milk  extract,  is  not  scientifically
studied.  Thus,  the  present  study  was  designed  to  investigate  the
hepatoprotective  activity  of  Piper  longum milk  extract.  Carbon tetrachloride
(CCl4) was used as a hepatotoxin at a dose of 0.5ml/kg p. o. with olive oil (1:1)
thrice  a  week  for  21  days  to  produce  the  chronic  reversible  type  of  liver
necrosis. Following treatment with Piper longum milk extract (200 mg/day p. o.
for 21 days), a significant hepatoprotective effect was observed in CCl4 induced
hepatic  damage  as  evident  from  decreased  level  of  serum  enzymes,  total
bilirubin and direct  bilirubin. The hepatoprotective effect of Piper longum is
comparable to the standard drug silymarin (25 mg/kg/day p. o. for 21 days).
Harish Chander Dutt et al,. 201277,78,79,80                                                              
The hepatoprotective effect of aqueous ethanol extract of Z. officinale against 
acetaminophen induced acute toxicity is mediated either by preventing the 
decline of hepatic antioxidant status or due to its direct radical scavenging 
capacity. Liver damage by CCl4 can also be prevented by the roots of the plant 
species. Ginger oleoresin when administered orally significantly lowered serum 
and hepatic cholesterol and increased faecal cholesterol excretion.
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Abdel-Tawab H. Mossa et al,. 201280,81,82
To evaluated the adverse effect of exposure to diazinon and paracetamol and
their combination on male rats. Significantly, decreased of body weights were
observed in all treated groups, while significant increase in relative liver weight
were recorded in DIA and DIA+PARA treated groups compared to control rats.
Liver  dysfunction  enzymes  (ALT,  AST,  ALP)  were  increased  in  DIA and
DIA+PARA treated group. DIA and DIA+PARA treated groups are significantly
changes in the biochemical and histopathalogical changesand decreases DNA
content in the rat liver cells.
Bhaskar VH et al,. 201083,84
Paracetamol toxicity is due to the formation of a toxic metabolite (N-acetyl-p-
benzoquinoneimine)  when  it  is  metabolized  by  cytochrome  P450s,  which
causes oxidative stress and glutathione depletion.
M. B. Shankar et al,. 2005
The hepatoprotective activity of a  new benzopyrone derivative (TP) isolated
from  the  alcoholic  extract  of  aerial  parts  of  Tephrosia  purpurea.
Hepatoprotective activity of TP and the alcoholic extract was evaluated using
carbon tetrachloride, paracetamol and rifampicin as toxicants. The potency of
TP (100  mg/kg)  and  the  alcoholic  extract  of  aerial  parts  (200  mg/kg),  was
compared  with  silymarin  (100  mg/kg).  The  SGOT,  SGPT,  total  and  direct
bilirubin  levels  of  blood  were  measured  spectrophotometrically  Alcoholic
extract of T. purpurea and TP have shown significant hepatoprotective activity
in rats against all the toxicants that were studied.
Galighor AE et al,. 1971
A Small  piece  of  liver  were  fixed  in  10%  neutral  buffered  formalin  and
subsequently embedded in paraffin. A transverse section of 5 µm was cut from
each  sample  and  stained  with  haematoxylin  and  eosin.  Histopathological
assessment (light microscopy) was performed on randomized sections of liver.
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Liver disease are the biggest threat to the world which is characterised
with  impaired  metabolic  secretary  function  of  liver  clinically  as  jaundice,
cirrhosis, hepatitis, liver cancer and ultimately liver failure. About 20,000 deaths
founds every year due to liver disorders. A common chronic disease known as
liver fibrosis may lead to end-stage  cirrhosis and liver  cancer.  Hepatocellulor
carcinoma is the one of the ten most common tumers in the world with over
2,50,000 new cases each year.
In the treatment of liver diseases in modern medicine cartico steroids and
immunosuppressants are commonly used to treat to liver disease in allopathic
form of medicine. But these drugs are associated with adverse effects such as
immunosuppression and bone marrow depression. Further,  the success rate of
treating liver diseases is disappointing. Attempts are being made globally to get
scientific evidence for this traditionally  reported herbal drugs.
Lawsonia  inermis  L.  belonging  to  the  family  of  lythraceae.  A shrub
commonly  known  as  mehendi  and  henna.  Mainly the  aim  of  the  study was
evaluate the hepatoprotective activity as evidence from the literature review.
The  lawsonia inermis is traditionally used in india for the treatment of
jaundice, enlargement of liver and spleen. It has been reported to possesses the
anti-inflammatory, anti-microbial and anti-cancer activity. Because the one of the
major active component of the leaves of  lawsonia inermis are flavanoids. The
hepatoprotective activity of warm aqueous extract of leaves of lawsonia inermis
has  been  reported.  But  detail  study of  hepatoprotectivity  has  not  done.  The
present study has been undertaken with aim to determine the hepatoprotective
activity of ethanolic extract of  lawsinia inermis in animal model by estimating
biochemical and histopathalogical parameters. 
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Synonym: lawsonia alba lam, lawsonia spinoza
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CLASSIFICATION36
Kingdom          : Plantae
Sub kingdom   : Tracheobionta
Super division : Spermotophyta
Division            :Magnoliophyta   
            Class   : Magnoliopsida
Subclass   : Rosidae
Order   :Myrtales
Family   :Lythraceae
Genus : Lawsonia L.
Species   :Lawsonia inermis L.
VERNACULAR NAMES37,38,39
English : Henna
Hindi : Mehndi
Kannada : Mayilanchi  
Malayalam : Mailanchi 
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Sanskrit : Rakigarbha,Mendika
Tamil : Maruthani 
Telugu:  Goranta
DISTRIBUTION39,40
                lawsonia inermis Linn native to north Africa and south east
asia, and often cultivated as an ornamental plant throughout india, Persia, and
along the African coast of the Mediterranean sea.
DESCRIPTION41,42
                         Lawsonia inermis  Linn (Lythraceae). is aglabrous branched
shrub or small tree (2 to 6 m in height). Leaves are small, opposite, entire margin
elliptical to broadly lanceolate, sub-sessile, about 1.5 to 5 cm long, 0.5 to 2 cm
wide, greenish brown to dull green, petiole short and glabrous acute or obtuse
apex with tapering base. New branches are green in colour and quadrangular,
turn red with age. Young barks are greyish brown, older plants have spine tipped
branchlets.  Inflorescence  has  large  pyramid  shape  cyme.  Flowers  are  small,
numerous, aromatic, white or red with four crumbled petals. Calyx has 0.2 cm
tube  and  0.3  cm spread  lobes.  The  fruits  are  small,  brown  globose  capsule,
opening irregularly and split into four section with a permanent style. Seeds have
typical, pyramidal, hard and thick seed coat with brownish coloration.           
CHEMICAL CONSTITUENTS43,44,45
The  chemical  constituents  isolated  from  leaves  of l.  inermis are  phenolic
compounds, phytosterols, coumarin, flavanoids and essential oils are present.   
Napthoquinone  derivatives:  Lawsone   (2-hydroxy  1,4-napthoquinone)  1,3-
dihydroxy naphthalene, 1,4-napthoquinone, 1,2-dihydroxy-4-glucosylnapthalene.
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Phenolic  compounds:  lawsoniaside  (1,3,4-trihydroxynapthalene  1,4-dibeta-D-
glucopyronoside),  lalioside  (2,3,4,6-tetrahydroxyacetoxy-2beta-D-
glucopyrasonide),  lawsoniaside  B  (3-(4-0-a-D-glucopyranosyl-3,5-dimethoxy)
phenyl-2E-propenol),  syringioside,  daphneside,  daphnorin,  agrimonolide  6-O-
Beta-D-glucopyrasonide,  (+)-pinoresinol  di-O-beta-D-glucopyranoside,
syringaresinol di-O-D-glucopyranoside, isoscutellarin.
Phytosterols:  lawsaritol (24beta-ethycholest-4-en-3beta-ol) stigmosterol and β-
sitosterol.
Flavonoids:  Apigenin-7-glucoside,  apigenin-4-glycoside,  luteolin-7-glucoside,
luteolin-3-glucoside.
Essential  oil:  -(z)-2-hexenol,  linalool,  α  ionone,  α-terpeneol,  β-ionone,
terpinolene, δ-3-carene and γ-terpineol.
             PARTS USED46
Fresh leaves.
TRADITIONAL USES47,48
Lawsonia  inermis  is  awell  known  ethnomedical  plant  used  cosmetically  and
medicinally for over 9,000 years. Its use in the Indian traditional folk medicines
is well documented. Below that table was indicates the use of different parts of
l. inermis  in traditional system of medicine.
Plant parts Traditional uses (as/in)
                   
Bitter,   astringent,  acrid,  diuretic,
emetic, edema, expectorant, adonyne,
anti-inflammatory,  constipating,
depurative,  liver  tonic,  haematinic,
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                      Leaves
styptic,  febrifuge,  trichogenuos,
wound,  ulcers,  srangury,  cough,
bronchitis,  burning  sensation,
cephalalgia,  hemicarnis,  lumbago,
rheumatalgia,  inflammations,
diarrhoea,  dysentery,  leprosy,
leucoderma,  scabies,  boils,
hepatopathy,  splenopathy,  anemia,
haemorrhages,  hemoptysis,  fever,
opthalmia,  amenorrhoea,  falling  of
hair, greyness of hair, jaundice.
   
                        Root
Bitter,  depurative,  diuretic,
emmenagogue,  abortifacient,  burning
sensation,  leprosy,  skin  disease,
amenorrhoea,  dysmenorrhoea  and
premature greying of hair.
         
                         Flowers
Cardiotonic,  refrigent,  soporific,
febrifuge,  tonic,  cephalalgia,  burning
sensation  ,cardiopathy,  amentia,
insomnia, fever.
 
                         Seeds
Antipyretic,  intellect  promoting,
constipating,  intermittent  fevers,
insanity, amentia, diarrhoea, dysentery
and gastropathy.
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Objectives:
The main objective of the study was evaluate the hepatoprotective activity of
ethanolic extract of the leaves of  Lawsonia inermis linn  in validated experimental
animals.
Step: 1
Idendification and authentification of plant  Lawsonia inermis linn  by renowed
taxonomist.
            Step: 2
Collection of leaves of Lawsonia inermis linn and its shade drying.
Step: 3
Extraction of the leaves of Lawsonia inermis using solvent of ethanol.
Step: 4
                        Evaluations of phytochemical constituents
Step: 5
Acute toxicity studies as per OECD guidelines.
Step: 6
Study the hepatoprotective activity of ethanolic extract of Lawsonia inermis
using paracetamol induced hepatotoxicity  model.
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Step: 7
Evaluations of following parameters
a)Biochemical parameters
  b)Histopathalogical studies.
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COLLECTION OF PLANT
         The leaves of lawsonia inermis linn were collected in June 2013, from
Telungupalayam,  Coimbatore  District,  Tamilnadu,  India. The  plant  was
taxonomically identified by the botanist Dr.M.Palanisamy scientist ‘C’ incharge,
Head  of  office,  Botanical  survey  of  India  ,  Southern  Regional  Centre,
Coimbatore – 641003..
EXTRACTION OF PLANT 
The collected leaves are washed with tap water and shade dried for 1 week. One
week after the drying, materials were converted in to coarse powder by using
mixer.  Taken  100g  of  coarse  powder  of  plants,  mixed  with  500ml  of  70%
ethanol in round bottom flask, which was kept under the process reflux for 72
hours by using Soxhlet apparatus. The extracts are dried under reduced pressure
and stored in desiccators. The residue (50 g) were collected and used for the
present investigation.
CHEMICALS
 Ethanol 70%.
 chloroform.
 Distilled water.
 Formalin solution.
 Carboxyl methyl cellulose.
DRUGS 32
 Paracetamol.
 Silymarin (100mg/kg)
SOLVENTS
Ethyl alcohol, Water, CMC (carboxyl methyl cellulose)
QUALITATIVE PHYTOCHEMICAL SCREENING
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The following tests were carried out on the standardized herbal extract to
detect the various phytoconstituents present in the plant extract.
1. TEST FOR CARBOHYDRATES
A small quqntity of the extract was dissolved in the distilled water and
filtered. The fitrate was subjected to the following test for carbohydrate.
a) Molisch’s Test
             To the filtrate few drops of alcoholic α-napthol was added and 2ml of
concentrated sulphuric acid was added slowly through the sides of the test tube. No
purple color of ring was formed, which indicates absence of carbohydrate.
b) Fehling’s Test 
            A small portion of the extract was treated with fehlings solution  A&B then
heated on water bath. No brick red colored precipitated was formed, which indicates
absence of carbohydrate.
c) Barfoed’s Test
             A small portion of the extract treated with barfoeds reagent. No red colored
precipitated was formed, which indicates absence of carbohydrate.
2. TEST FOR STARCH
             A small portion of the extract was treated with dilute iodine solution. No blue
color was formed, which indicates absence of starch.
3. TEST FOR AMINO ACIDS AND PROTEINS
             A small quantity of the extract was dissolved in the disstiled water and filtered.
The filtrate was subjected to millions and biured test and ninhydrin test.
a) Million’s Test
The filtrate  is  treated  with millons reagent.  No white  precipitated was
produce, which indicates absence of protein and amino acids in the filtrate.
b) Biuret Test
To the filtrate equal volume of 5% w/v of NaOH and four drops of 1%w/v
CuSO4 solution were added. No purple or red color was formed, so it indicates
absence of protein.
c) Ninhydrin Test
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The filtrate is treated with ninhydrin reagent. No purple color was formed
indicating absence of protein.
4. TEST FOR PHENOLIC COMPOUNDS
Small quantities of the extracts were taken separately in water and test for
the  presence  of  phenolic  compounds  and  tannins  was  carried  out  with  the
following reagents.
a) Ferric Chloride Test
the filtrate was treated with 5% of ferric chloride solution. Black color of
precipitate  is  formed,  which  indicates  presence  of  and  tannins  phenolic
compounds.
b) Lead Acetate Test
few ml of filtrate is treated with lead acetate solution. White precipitate
was produced, it indicate presence of phenolic compounds.
c) Gelatin Test
To the filtrate add 1ml of gelatin solution. White colour precipitate was
seen indicate presence of tannins.
5. TEST FOR PHYTOSTEROL
The extract was refluxed with solution of alcoholic potassium hydroxide
till  complete  saponification  has  taken  place.   The  mixture  was  diluted  and
extracted with ether.  The ether layer was evaporated and the residue was tested
for the presence of phytosterol.
a) Libermann Burchard Test
The residue was dissolved in few drops of dil.   Acetic acid;  3 ml of
acetic  anhydride  was added  followed by few drops  of  Con.  Sulphuric  acid.
Bluish green color shows the absence of phytosterol.
6. TESTS FOR ESSENTIAL OILS
Spot Test
A small quantities of various extracts were separately pressed between
two filter papers.  Appearance of oil stain on the paper indicates the presence of
fixed oil.   Few drops of  0.5N alcoholic potassium hydroxide were added to
small quantity of various extracts along with a drop of phenolphthalein.  The
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mixture was heated on a water bath for 1-2 hours.  Formation of soap or partial
neutralization of alkali indicates the presence of oils.
7. TEST FOR ALKALOIDS
A small portion of the solvent free alcohol and aqueous extracts were
stirred separately with few drops of dilute hydrochloric acid and filtered.  The
filtrate was tested with various reagents for the presence of alkaloids.
a) Mayer’s Test
 To the small amount of the filtrate was treated with mayer’s reagent. No
white color of precipitated was formed, indicatings absence alkaloids.
b) Dragendroff’s Test
To  the  small  amount  of  the  filtrate  was  treated  with  Dragendroff’s
reagent. No orange or red color was formed, indicating absence of alkaloids.
c) Wagner’s Test
To a small amount of the filtrate is treated with Wagner’s reagent. No
brown color precipitate formed, indicating absence of alkaloids.
d) Harger’s Test
To the small amount of the filtrate is treated with few drops of Harger’s
reagent.  No  yellow  crystalline  precipitate  formed,  indicating  absence  of
alkaloids.
8. TESTS FOR GLYCOSIDES
a) Legal’s Test
To the hydrolysate I ml of pyridine and few drops of sodium nitropruside
solutions  were added and then it  was made alkaline with sodium hydroxide
solution.  Appearance of pink to red colour shows the presence of glycosides.
b) Bortanger’s Test:
Hydrolysate was treated with choloroform and then the chloroform layer
was  separated.   To  this  equal  quantity  of  dilute  ammonia  solution  added.
Ammonia layer acquires pink color, showing the presence of glycosides.
9. TEST FOR FLVAVONOIDS
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The extract  was dissolved in ethanol  and then subjected to  following
test.
a) Ferric Chloride Test
To a small quqntity of the ethanol extract with few drops of neutral ferric
chloride  solution was  added.  Blackish  red  color  was  observed,  showing the
presence of flavonoids.
b) Shinoda’s Test
To a Small quantities of the extract were dissolved in alcohol, to them
piece of magnesium followed by Conc. Hydrochloric acid drop wise added and
heated.  Appearance of magenta color shows the presence of flavonoids.
c) Concentrating Sulphuric Acid test
To a small quantity of the extract was treated with concentrated H2SO4.
Yellow orange color, presence of flavanoids.
d) Lead acetate test
To a  small  quantity  of  the  extract  was  treated  with  10% lead  acetate
solution. to form yellow color precipitate indicating presence of flavanoids.
10. TEST FOR COUMARINS
To a small quantity of the extract were dissolved in alcohol and ferric
chloride solution, shows green color, indicating presence of coumarins.
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PROCEDURE80
Preparation of animals
The animals are randomly selected, marked to permit individual identification,
and  kept  in  their  cages  for  at  least  5  days  prior  to  dosing  to  allow  for
acclimatisation to the laboratory conditions.
Preparation of doses
In general test substances should be administered in a constant volume over the
range  of  doses  to  be  tested  by  varying  the  concentration  of  the  dosing
preparation. Where a liquid end product or mixture to be tested however, the use
of the undiluted test substances, i.e. at a constant concentration, may be more
relevant to the subsequent risk assessment of the substances, and is a requirement
of  some regulatory authorities.  In  either case,  the maximum dose volume for
administration must not be exceeded.  The maximum volume of the liquid that
can  be  administrated  at  one  time depends  on  the  size  of  the  test  animal.  In
rodents, the volume should not normally exceed 1ml/100 gm of body weight.
However  in  the  case  of  aqueous  solution  2ml/100  gm  body  weight  can  be
considered. With respect to the formulation the dosing preparation, by use of an
aqueous  solution/  suspension/  emulsion  is  recommended  wherever  possible,
followed in order of preference by solution/suspension/emulsion in oil ex. (Corn
oil)  possible  solution  in  other  vehicle.  For  vehicles  other  then  water  the
toxicological  characteristics  of  the  vehicle  should  be  known.  Doses  must  be
prepared shortly prior to administration unless the stability of the preparation
over  the  period  during  which  it  will  be  used  is  known  and  shown  to  be
acceptable.
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Administration of the dose
The  test  substance  is  administered  in  a  single  dose  by  gavages  by  using  a
stomach tube or suitable incubation cannula. In the unusual circumstance that a
single dose is not possible, the dose may be given in small fraction over period
not exceeding 24 hours. 
Animal should be fasted prior to dosing (e.g. with rat, food but not water should
be withheld over night, with the mouse food but not water should be withheld for
3-4 hours) following the period of fasting, the animal should be weighed and the
test substances is administered. After the substance has been administered, food
may be withheld for a further 3-4 hours in rats or 1-2 hours in mice. Where a
dose is administered infraction over a period it may be necessary to provide the
animals with food and water depending on the length of period.   
Number of the Animal and Dose Levels
Three animals are used for each step. The dose level to be used as the starting
dose is selected from one hour of four fixed levels, 5, 50, 300, 2000 mg/kg body
weight. The starting dose level should be that which is most likely to produce
mortality in some of the dosed animals. 
When available  information  suggests  that  mortality is  unlikely at  the  highest
starting  dose  level  (2000  mg/kg  body  weight),  then  a  limit  test  should  be
conducted. When there is no information on a substance to be tested, for animal
welfare  reasons  it  recommended  using  the  starting  dose  of  300  mg/kg  body
weight.
The time interval between treatment groups is determined by the onset, duration,
and severity of  toxic signs.  Treatment  of  animals at  the next  dose should be
delayed until one is confident of survival of the previously dosed animals.
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Exceptionally, and only when one justified by specific regularity needs the use of
additional  upper dose level  5000 mg/kg body weight may be considered. For
reason of animal welfare concern, testing of animals in GHS category 5 ranges
(2000 – 5000 mg/kg) is discouraged and should only be considered and when
there is a strong likelihood that results of such a test have direct relevance for
protecting human or animal health or the environment.
Limit test:
The  limit  test  is  primarily  used  in  situations  where  the  experimenter  has
information indicating that the test material is likely to be nontoxic, i.e., having
toxicity only above regulatory limit doses. Information about the toxicity of the
test material can be gained from knowledge about similar tested compounds or
similar tested mixtures are products, taking into consideration the identity and
percentage of components known to be toxicological significance.
    A limit test at one dose level of 2000 mg/kg body weight may be carried out
with six animals (3 animals per step). Exceptionally a limit test at one dose level
of  5000  mg/kg  may be  carried  out  with  3  animals.  If  test  substance-related
mortality is  produced,  further  testing at  the next lower level  may need to  be
carried out.
Test report:
• Tabulation of response data and dose level for each animal (i.e. animal showing
signs  of  toxicity  including  mortality;  nature,  severity,  and  duration  of  side
effects);
• Tabulation of body weight and body weight changes;
• Individual weights of animals at the day of dosing, in weekly intervals thereafter,
and at the time of death or sacrifice;
• Date and time of death if prior to scheduled sacrifice;
• Time course of onset of signs of toxicity, and whether these were reversible for
each animals;
• Necropsy findings and histopathological findings for each animal.
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SCREENING METHODS FOR HEPATOPROTECTIVE ACTIVITY
ANIMALS
             Studies were carried out using either sex wister albino rats (160-200g) and
swiss  albino  mice  (18-25  g).They were   obtained  from the  animal  house  of  agri
culture  university,  trissur,  kerala,  india.  The animals  were  grouped  and housed  in
polyacrylic  cages  (38×23×10  cm)  with  not  more  than  six  animals  per  cage  and
maintained  under  standard  laboratory  condition  (temperature  25±2°C),  relative
humitity (55±5% ) with dark and light cycle (12/12 h). They were allowed to standard
pellet diet (Amrut feed, Hindustan lever, Bangalore, india) and water ad libitum. The
rats were acclimatized to laboratory condition for 10 days before commencement of
experiment. The animal studies were approved by the committee for the control and
supervision  of  experiment  on animals  (CPCSEA) and  conducted  according to  the
regulation  of  Institutional  Animal  Ethics  Committee(IAEC)  with  project
No.M.Pharma/13/10.
EXPERIMENTAL DESIGN81,82
PARACETAMOL-INDUCED HEPATOTOXICITY
Group I -      Normal  Control ( normal saline 5ml/kg,  p.o)
Group II - Toxicant ( paracetamol 2g/kg, p.o)
Group III - Standard drug treated ( silymarin 100mg/kg, p.o)
Group IV - plant extract (EELI 200mg/kg, p.o)
Group V - plant extract (EELI 400mg/kg, p.o)
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EXPERIMENT PROCEDURE83,84
Paracetamol induced hepatotoxicity model was adobted for the study. The rats
were divided into 5 groups of 6 animals each. Group I served as a normal control and
received normal saline, 5 ml/kg body weight, daily for 7 days. Group II constituted
the hepatotoxicity group and were treated similarly to group I. Group IV and group V
received ethanolic extract  (200 and 400 mg/kg body weighy per day, respectively)
suspended in 0.5% sodium carboxy methyl cellulose for 7 days. Group III received
the standard drug, silymarin (100 mg/kg body weight daily) for 7 days. On the 7 th
day after 2 hours of respective treatment, paracetamol suspension was given orally, 2
g/kg  body  weight,  to  all  the  rats  except  those  in  group  I.  At  the  end  of  the
experimental period, the rats were fasted overnight and blood samples were collected
from retro-orbital plexus for biochemical studies and animals are  sacrificed under
anesthesia (pentobarbitone sodium, 45mg/kg).Then liver samples were collected for
histopathological studies.
BIO-CHEMICAL STUDIES88,89,90
Blood was obtained from all animals by puncturing the retro-orbital plexus.
Blood samples  were  allowed to  clot  for  45 min at  room temperature.  Serum was
separated by centrifugation for 3000 rpm for 10 minutes to separate the serum. The
separated blood serum was analyzed for the biochemical markers of SGPT (ALT),
SGOT (AST), ALP, Bilirubin, Total protein levels.
HISTOPATHALOGICAL STUDIES91
After the collection of blood samples, animals were sacrificed, liver
samples collected, washed with normal saline and were fixed in 10% buffered neutral
formalin for 48 hours and then washed with water to remove fixative. The tissue were
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fixed  in  bouins  solution  for  six  hours  and  processed  for  microtome  section  and
examined in light microscope. 
STATISTICAL ANALYSIS
The  results  were  expressed  as  Mean  ±  S.D,  (N=6).  Statistical  significant
values were determined by one-way analysis (ANOVA) followed by  Dunnett’s test.
P<0.05 was considered significant. 
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Table-1
CHEMICAL CONSTITUENTS OF DIFFERENT EXTRACTS 
           OF LEAVES OF LAWSONIA INERMIS LINN
Chemical
Constituents
Aqueous
extract
Non  aqueous
extract
Carbohydrates - -
Glycosides - -
Alkaloids - -
Flavonoids + +
Phenols + +
Fixed oils - +
Steroids + +
Saponins         + -
Gums  &
mucilage - -
Proteins  &  free
amino acids - -
Tannins + +
Terpenoids + -
(+)  → Positive
(-)  → Negative
ACUTE ORAL TOXICITY FOR EELI
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EFFECT OF EELI ON SERUM ENZYMES IN
PARACETAMOL INDUCED HEPATOTOXICITY
Treatment
/group 
(Mg/kg, P.O)
ALP ALT AST Totalbilirubin
Total
protein
Control
Normal
saline
(5ml/kg)
31±0.5
77
50.66±
1.667
46.33
±0.88
1
0.416±0.
008
5.833±
0.1202
   Negative
control
(PCM
2gm/kg)
96±2.5
17
220.07
±5.774
196.6
6±12.
020
2.246±0.
008
7.8±0.
1528
Standard
drug
Treated
Silimayrin
(100mg/kg)
34.66±
0.881
53.66±
1.856
48.33
±1.20
2
0.53±0.0
05
5.366±
0.1202
Plant extract
(EELI
200mg/kg)
50.33±
2.963
81.33±
0.881
74.33
±4.70
2
0.97±0.0
12
6.566±
0.1202
Plant extract
(EELI
400mg/kg)
36
± 1.
555
54.07±
2.517
0.48±
0.018
0.48±0.0
18
6.000±
0.0577
The Paracetamol induced Hepatotoxicity in rats, results have expressed on Table.
All  the  groups  of  animals  were  affected  in  Hepatotoxicity,  ethanolic  extract  of
Lawsonia inermis treated groups 200 & 400 mg/kg were dose dependent manner
decreased  ALP  &  ALT  &  AST  levels  (P<0.001)**&   (P<0.0001)***
(36±1.555**↓&54.07±2.517**↓),(0.48±0.018↓).When  compared   with  negative
control  group  but  positive  control  have  less  Hepatotoxicity   (P<0.001)**&
(P<0.0001)*** When compare to  each groups of  ethanolic extract  of Lawsonia
inermis  400  mg/kg  have  high  Hepatoprotective  activity  (0.48±0.018**↓&
6.000±0.0577**↓). When compared with positive control.
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Bilurubin
0.0
0.5
1.0
1.5
2.0
2.5
GROUPS
m
g/
dl
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HISTOPATHOLOGICAL REPORT
Figure: 1 Control group (Normal saline 5ml/kg)
IMPRESSION:
                        Section of liver in normal control group (A) shows liver 
parenchyma with normal architecture of hepatic cells.
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Figure: 2 Negative Control group (PCM 2gm/kg)
        
    
IMPRESSION:
                           Section of liver in Negative control group (B)
shows partially effaced architecture.  Some of  the hepatocytes  show apoptotic
changes,  perivenular  mononuclear  inflammatory  infiltration,  and  scattered
inflammatory infiltration with in the parenchyma.     
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Figure: 3 Standard drug treated group (silymarin 100mg/kg)
IMPRESSION:
                       Section of liver in standard drug treated group (C) shows liver 
parenchyma with intact architecture of hepatocytes.. Some of the central veins 
show congestion with diffuse congestion of sinusoids.
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Figure: 4 Plant extract treated group (EELI 200 mg/kg) 
IMPRESSION:
              Plants extract treated group (D) showing mild degeneration of
and reverting to regeneration of hepatocytes, sinusoidal congestion and scattered
mononuclear inflammatory cells. 
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Figure: 5 plant extract treated group (EELI 400 mg/kg)
IMPRESSION:
    Plant  extract  treated  group  (E)  shows  intact  architecture,
complete regeneration of  heaptocytes,  sinusidal  congesion which is  similar  to
silymarin treated(C) group.
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DISCUSSIONS
The purpose of  the study was exploring the hepatoprotective effect  of
ethanolic  extract  of  lawsonia  inermis  leaves  against  paracetamol  induced
hepatotoxicity in rats.
The hepatotoxic effect  of the paracetamol is  due to formation of toxic
metabolite  (N-acetyl-p-benzoquinoneimine)  when  it  is  metabolised  by
cytochrome P-450, which causes oxidative stress and glutathione depletion.
The  animals  treated  with  paracetamol  had  markedly  elevated
values of the biochemical parameters including SGOT, SGPT, ALP, bilirubin and
the level  of total  protein decreased compared to normal group of animals,  its
indicating  acute  hepatocellulor  damage.  Pretreatment  with  EELI  (200  &
400mg/kg)  made  the  serum  values  such  as  SGOT,  SGPT,  ALP significantly
lower  than  toxic  control  values.  The  total  bilirubin  value  was  found  to  be
significantly  reversal.  Which  is  near  to  the  normal  control  value?  The  total
protein level was significantly increased compared to the toxic control group.
From  the  results  EELI  (200  &  400mg/kg)  showed  significant
hepatoprotective activity, as evidence by the biochemical and histopathalogical
parameters.  The  protective  effect  of  EELI  against  paracetamol  induced
hepatotoxicity  induced  rats.  This  effect  presence  of  flavanoids  (Apigenin-7-
glycosides)  demonstrating  hepatoprotective  activity  in  ethanolic  extract  of
Lawsonia inermis L. leaves. 
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                    The hepatoprotective effect of ethanolic extract of lawsonia inermis leaves
was confirmed by the biochemical and histopathalogical studies.
             In biochemical studies serum marker enzymes such as SGOT, SGPT,
ALP, bilirubin  showed marked increase and decrease in the level of protein. The
same  is  observed  in  liver  disease  in  clinical  practice  and  hence  are  having
diagnostic importance in the assessment of liver function test.
             In the present study, the ethanolic extract of lawsonia inermis leaves
significantly  reduced  the  elevated  levels  of  above  mensioned  serum  marker
enzymes and increase in the level of protein. Hence at this point concluded the
ethanolic extract of lawsonia inermis leaves posses  hepatoprotective activity.
In support to this study, histopathalogical results also show significant
activity of the plant. In toxicant treated animals there will be severe disturbances
in the cytoarchitecture of the liver. But in ethanolic extract of lawsonia inermis
leaves  treated  group  animals  exhibited  minimal  hepatic  dearrangrments  and
intact cytoarchitecture of the liver was maintained. In addition to this there is
regeneration  of  hepatocytes  also  observed,  which  indicating  hepatoprotective
activity.
Finally based on the improvement in serum marker enzyme level, and
histopathalogical studies. It is concluded that the ethanolic extract of  lawsonia
inermis leaves posses hepatoprotective activity.
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